Zevra Therapeutics
Manufacturing · Florida, United States · 65 Employees
View Company Info for Free
About
Headquarters
1180 Celebration Blvd Ste 103, Celebration, Flo...Phone Number
(888) 958-1253Website
www.zevra.comRevenue
$27.7 MillionStock Symbol
ZVRAIndustry
Most Recent Scoops
Highlights
$182.1M
Total Funding Amount
<$5M
Most Recent Funding Amount
5
Number of Funding Rounds
Who is Zevra Therapeutics
We are a rare disease therapeutics company leading with science to make life-changing therapeutics available to patients with significant unmet nee ds. We involve key thought leaders, physicians, patients, care partners and advocacy groups in all of our clinical and regulatory development strategies. With a keen understanding that drug development often requires creative solutions, we have the insight and expertise to forge new pathways to success that others have missed. By following the data without bias, our transparent narratives and common-sense perspective have successfully overcome complex development challenges to make much-needed therapies available to patients.Read more
Popular SearchesZevra TherapeuticsZevra Therapeutics IncZevraZevra Therapeutics - BenzingaZevra Therapeutics ExpandsSIC Code 28,283NAICS Code 32,325Ticker NASDAQ: ZVRAShow moreZevra Therapeutics Org Chart
Is Zevra Therapeutics your ideal customer?
Let us give you the heads up on whether it's a good time to reach out
Click to see if Zevra Therapeutics had a recent Job posting/layoffs
Product Launch: Get notified when Zevra Therapeutics launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Zevra Therapeutics has new funding data
Earning: See what the market has to say on Zevra Therapeutics recently announced quarterly report
Check out if Zevra Therapeutics is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Zevra Therapeutics
Website visits: Recent activity has been detected on your website
Zevra Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Zevra Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Similar Companies to Zevra Therapeutics
Analyze insights from companies similar to Zevra Therapeutics and make strategic comparisons based on performance, financial data, growth and unique benchmarks.
- True North Therapeutics<25$5.6M
- NASH Roundtable34<$5M
- Eloxx Pharmaceuticals<25$6.1M
- Orphazyme62$5.2M
- Translational Drug Development...<25<$5M
- Lysosomal Therapeutics<25<$5M
- ProSciento205$38.8M
- Neuraly62$12.2M
More similar companies
Zevra Therapeutics financials insights
Gather financial insights about Zevra Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
Zevra Therapeutics Employee Growth Rate
Percentage of growth
1st year Mask
2nd year Mask
Zevra Therapeutics Tech Stack
A closer look at the technologies used by Zevra Therapeutics
Most Recent Scoops
Zevra Therapeutics News & Media
Zevra Therapeutics to Report Third Quarter 2024 Financial Results and Provide Corporate Update on Nov. 12, 2024
Company will host conference call at 4:30 p.m. ET that day Company will host conference call at 4:30 p.m. ET that dayZevra Therapeutics to Participate in Rare Disease Panel at the 2024 Maxim Healthcare Virtual Summit, Presented by Maxim Group LLC
CELEBRATION, Fla., Oct. 10, 2024 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company), a rare disease therapeutics company, today announced that Neil F. McFarlane, President and Chief Executive Office of Zevra, will participate in a Rare Disease Panel at the 2024 Maxim Healthcare Virtual Summit, presented by Maxim Group LLC on Thursday, October 17, 2024 at 2 p.m. ET.NUCDF and Zevra Therapeutics Launch Check Ammonia Campaign to Highlight Critical Importance of Prompt, Accurate Blood Ammonia Testing for Diagnosing Urea Cycle Disorders
Patients, providers, and public are invited to help save lives by sharing messages and materials Patients, providers, and public are invited to help save lives by sharing messages and materialsOrsini Chosen as the Exclusive Specialty Pharmacy Provider for MIPLYFFA™ (arimoclomol), the First FDA-Approved Treatment for Niemann-Pick Disease Type C
ELK GROVE VILLAGE, Ill., Sept. 24, 2024 /PRNewswire/ -- Orsini today announced that Zevra Therapeutics, Inc. (Zevra) has selected them as the exclusive specialty pharmacy partner for MIPLYFFA™ (arimoclomol), the first FDA-approved treatment for Niemann-Pick disease type C (NPC), an...
Top Companies in United States
Top 10 companies in United States by revenue
Top 10 companies in United States by number of employees
Top 10 companies in United States by total funding amount
Frequently Asked Questions Regarding Zevra Therapeutics
We are a rare disease therapeutics company leading with science to make life-changing therapeutics available to patients with significant unmet needs. We involve key thought leaders, physicians, patients, care partners and advocacy groups in all of our clinical and regulatory development strategies. With a keen understanding that drug development o... Read More